181 related articles for article (PubMed ID: 38657045)
1. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.
Trierweiler C; Hockenjos B; Zatloukal K; Thimme R; Blum HE; Wagner EF; Hasselblatt P
Cell Death Differ; 2016 Apr; 23(4):576-82. PubMed ID: 26470729
[TBL] [Abstract][Full Text] [Related]
3. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
4. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S
Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
6. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract][Full Text] [Related]
7. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
[TBL] [Abstract][Full Text] [Related]
8. Expression of activator protein-1 (AP-1) family members in breast cancer.
Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
BMC Cancer; 2013 Sep; 13():441. PubMed ID: 24073962
[TBL] [Abstract][Full Text] [Related]
9. Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.
Hasenfuss SC; Bakiri L; Thomsen MK; Williams EG; Auwerx J; Wagner EF
Cell Metab; 2014 Jan; 19(1):84-95. PubMed ID: 24411941
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
12. Genetic disruption of Fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice.
Vaz M; Reddy NM; Rajasekaran S; Reddy SP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):55-62. PubMed ID: 21816965
[TBL] [Abstract][Full Text] [Related]
13. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.
He W; Wu Y; Tang X; Xia Y; He G; Min Z; Li C; Xiong S; Shi Z; Lu Y; Yuan Z
Oncotarget; 2016 Feb; 7(6):6727-47. PubMed ID: 26734995
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D.
Hanley K; Wood L; Ng DC; He SS; Lau P; Moser A; Elias PM; Bikle DD; Williams ML; Feingold KR
J Lipid Res; 2001 Mar; 42(3):390-8. PubMed ID: 11254751
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
Ritorto MS; Rhode H; Vogel A; Borlak J
Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
[TBL] [Abstract][Full Text] [Related]
16. Promoter specificity and biological activity of tethered AP-1 dimers.
Bakiri L; Matsuo K; Wisniewska M; Wagner EF; Yaniv M
Mol Cell Biol; 2002 Jul; 22(13):4952-64. PubMed ID: 12052899
[TBL] [Abstract][Full Text] [Related]
17. Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.
Talotta F; Mega T; Bossis G; Casalino L; Basbous J; Jariel-Encontre I; Piechaczyk M; Verde P
Oncogene; 2010 Aug; 29(33):4732-40. PubMed ID: 20543861
[TBL] [Abstract][Full Text] [Related]
18. Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
Hein S; Mahner S; Kanowski C; Löning T; Jänicke F; Milde-Langosch K
Oncol Rep; 2009 Jul; 22(1):177-83. PubMed ID: 19513521
[TBL] [Abstract][Full Text] [Related]
19. Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis.
Li X; Shi ZM; Feng P; Wen ZY; Wang XJ
World J Gastroenterol; 2007 Aug; 13(31):4192-8. PubMed ID: 17696247
[TBL] [Abstract][Full Text] [Related]
20. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
